Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015;8(2):147-55.
doi: 10.1159/000381224.

Fatty Acids, Obesity and Insulin Resistance

Fatty Acids, Obesity and Insulin Resistance

Peter Arner et al. Obes Facts. 2015.

Abstract

Objective: Although elevated free fatty acid (FFA) levels in obesity have been considered to be of importance for insulin resistance, a recent meta-analysis suggested normal FFA levels in obese subjects. We investigated fasting circulating FFA and glycerol levels in a large cohort of non-obese and obese subjects.

Methods: Subjects recruited for a study on obesity genetics were investigated in the morning after an overnight fast (n = 3,888). Serum FFA (n = 3,306), plasma glycerol (n = 3,776), and insulin sensitivity index (HOMA-IR,n = 3,469) were determined. Obesity was defined as BMI ≥ 30 kg/m 2 and insulin resistance as HOMA-IR ≥ 2.21.

Results: In obese subjects, circulating FFA and glycerol levels were higher than in non-obese individuals (by 26% and 47%, respectively; both p < 0.0001). Similar results were obtained if only men, women or medication-free subjects were investigated. Insulin resistance and type 2 diabetes were associated with a further minor increase in FFA/glycerol among obese subjects. When comparing insulin-sensitive non-obese with insulin-sensitive or -resistant obese individuals, FFA and glycerol were 21–29% and 43–49% higher in obese individuals, respectively.

Conclusion: Circulating FFA and glycerol levels are markedly elevated in obesity but only marginally influenced by insulin resistance and type 2 diabetes. Whether these differences persist during diurnal variations in circulating FFA/glycerol, remains to be established

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Fasting serum FFA levels. A is distribution of values. B is findings in women. C is findings in men. D is findings in healthy men and women put together. Values were compared by unpaired t-test.
Fig. 2
Fig. 2
Fasting plasma glycerol levels. See text to figure 1 for further details.
Fig. 3
Fig. 3
Fasting serum FFA (A) and plasma glycerol (B) in non-obese or obese subjects with or without insulin resistance. INSO = Insulin sensitive non-obese; IRNO = insulin resistant non-obese; ISO =insulin sensitive obese; IRO = insulin resistant obese. Values were compared by ANCOVA (p < 0.0001) and Fishers PLSD post-hoc test (values in graphs). Letters (A-C) denote statistically significant differences between groups.

References

    1. Arner P. Free fatty acids – do they play a central role in type 2 diabetes? Diabetes Obes Metab. 2001;3((suppl 1)):S11–19. - PubMed
    1. Karpe F, Dickmann JR, Frayn KN. Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes. 2011;60:2441–2449. - PMC - PubMed
    1. James WPT, for the Department of Health and Social Security and the Medical Research Council . Research on Obesity: A Report of the DHSS/MRC group. London Her Majesty's Stationery Office; 1976.
    1. Charles MA, Fontbonne A, Thibult N, Claude JR, Warnet JM, Rosselin G, Ducimetiere P, Eschwege E. High plasma nonesterified fatty acids are predictive of cancer mortality but not of coronary heart disease mortality: results from the Paris prospective study. Am J Epidemiol. 2001;153:292–298. - PubMed
    1. Tan GD, Neville MJ, Liverani E, Humphreys SM, Currie JM, Dennis L, Fielding BA, Karpe F. The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank. Diabetologia. 2006;49:158–168. - PubMed

Publication types